share_log

Pfizer | DEFA14A: Others

Pfizer | DEFA14A: Others

輝瑞 | DEFA14A:其他
SEC announcement ·  04/09 22:34
牛牛AI助理已提取核心訊息
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as a vote reminder. This filing, identified as DEFA14A, is part of the Schedule 14A Proxy Statement, which is required under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Pfizer as the registrant, indicating that the company is directly involved in the solicitation of proxies from shareholders. No filing fee was required for this submission. The purpose of these materials is to remind shareholders to vote, an important aspect of corporate governance and shareholder engagement.
輝瑞公司已向美國證券交易委員會(SEC)提交了明確的補充材料作爲投票提醒。該文件名爲 DEFA14A,是附表14A委託書的一部分,該委託書是1934年《證券交易法》第14(a)條所要求的。這些材料是由輝瑞作爲註冊人提交的,表明該公司直接參與了向股東征集代理人的活動。本次提交無需繳納任何申請費。這些材料的目的是提醒股東投票,這是公司治理和股東參與的一個重要方面。
輝瑞公司已向美國證券交易委員會(SEC)提交了明確的補充材料作爲投票提醒。該文件名爲 DEFA14A,是附表14A委託書的一部分,該委託書是1934年《證券交易法》第14(a)條所要求的。這些材料是由輝瑞作爲註冊人提交的,表明該公司直接參與了向股東征集代理人的活動。本次提交無需繳納任何申請費。這些材料的目的是提醒股東投票,這是公司治理和股東參與的一個重要方面。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。